Melanie Leydin
Director of Finance/CFO at PRESCIENT THERAPEUTICS LIMITED
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mathew Watkins | M | - | 6 years | |
| Peter Hugh Lloyd | M | - | 39 years | |
| Shane Tanner | M | 70 | 19 years | |
| Laura McBain | F | - | 7 years | |
| Stefan Ross | M | - | 6 years | |
| Sam Riggall | M | 51 | 11 years | |
| Justin Walter | M | - | 8 years | |
| Ted Dhanik | M | - | 7 years | |
| Richard H. Irving | M | - | - | |
| Paul Salter | M | - | 11 years | |
| Rebecca Wilson | F | - | 7 years | |
| Roksan Libinaki | M | - | 23 years | |
| Simon Eley | M | 50 | 6 years | |
| Michael Andrews | M | - | - | |
| Shaun Verner | M | - | 8 years | |
| Steven Yatomi-Clarke | M | - | 10 years | |
| Julie Phillips | F | - |
BioDiem Ltd.
 BioDiem Ltd. Pharmaceuticals: MajorHealth Technology BioDiem Ltd. operates as a biotechnology company. It focuses on development and commercialization of pharmaceutical and biomedical research, vaccines and infectious disease therapies and securing licences of biopharmaceutical products currently under development. The firm's development programs include: expansion of the live attenuated influenza virus-based flu vaccine licensing business, development of the antimicrobial BDM-I for the treatment of serious infectious diseases, scrambled antigen vaccine and viral vector systems. The company was founded on May 18, 2001 and is headquartered in South Melbourne, Australia. | 15 years |
| Stephen Moulton | M | - | 7 years | |
| Gregory Collier | M | - | 9 years | |
| Kurtis Rintala | M | 53 | 7 years | |
| Benjamin Stockdale | M | - | 11 years | |
| Matthew Driscoll | M | 60 | 16 years | |
| John Sood | M | - | 16 years | |
| Brendan Boyd | M | - | 16 years | |
| Brendan Jesser | M | - | 10 years | |
| Pauline Gately | F | 62 | 5 years | |
| Mark Lochtenberg | M | - | - | |
| John Walstab | M | - | 2 years | |
| Stephenie Pulis-Cassar | M | - | 15 years | |
| Julian Challingsworth | M | - | 2 years | |
| Victoria Weekes | F | - | 3 years | |
| David Detata | M | - | 7 years | |
| Richard Morrow | M | - | 3 years | |
| David Niall | M | - | - | |
| Simon Chamberlain | M | - | 5 years | |
| Naomi Lawrie | F | - | 1 years | |
| Kevin MacNeill | M | - | 5 years | |
| David Trimboli | M | - | 2 years | |
| Oliver Kleinhempel | M | 42 | 5 years | |
| Thomas Young | M | - | 2 years | |
| Greg Keane | M | - | 7 years | |
| Todd Williams | M | - | 6 years | |
| Stefanie Loader | F | - | 7 years | |
| Kevin Shaw | M | - | 3 years | |
| Louise Thurgood | F | - | 3 years | |
| Kate Quirke | F | - | 6 years | |
| Thian Chew | M | - | 7 years | |
| Mathew O’Hara | M | - | 3 years | |
| Kaye Hocking | F | - | - | |
| Richard John Loveridge | M | - | 7 years | |
| Stuart Rechner | M | 44 | 10 years | |
| Jose Caldeira | M | - | 10 years | |
| Eric Finlayson | M | 63 | 9 years | |
| Stephen Layton | M | - | 7 years | |
| Ian Zacharia Tchacos | M | - | 8 years | |
| Robin Widdup | M | - | 6 years | |
| Jim Askew | M | 74 | 10 years | |
| Ross Murdoch | M | - | 9 years | |
| Simon O'Loughlin | M | 66 | 5 years | |
| Leo de Maria | M | - | 10 years | |
| Peter Hood | M | - | 6 years | |
| Geoffrey Sam | M | - | 8 years | |
| Simon Taylor | M | - | 5 years | |
| Sara Watts | F | - | 5 years | |
| Peter Doyle | M | - | 7 years | |
| Richard John Malcolm | M | 71 | 6 years | |
| Craig Smyth | M | 51 | 3 years | |
| Domenic Panaccio | M | - | 2 years | |
| Jason Eveleigh | M | - | 8 years | |
| Paul Donnelly | M | - | 6 years | |
| David Clark | M | - | 10 years | |
| John Beevers | M | - | 4 years | |
| Andrew Demetriou | M | 63 | 10 years | |
| Terry Sinclair | M | - | 4 years | |
| Jerko Zuvela | M | - | 10 years | |
| Daniel Sharp | M | - | 3 years | |
| David Dearie | M | - | 5 years | |
| Paul David Gavin | M | - | 22 years | |
| Lisa Bahash | F | - | 6 years | |
| Ellen Feigal | M | 69 | 1 years | |
| Claire Newstead-Sinclair | F | - | 3 years | |
| Damien Hannes | M | 68 |
BioDiem Ltd.
BioDiem Ltd. Pharmaceuticals: MajorHealth Technology BioDiem Ltd. operates as a biotechnology company. It focuses on development and commercialization of pharmaceutical and biomedical research, vaccines and infectious disease therapies and securing licences of biopharmaceutical products currently under development. The firm's development programs include: expansion of the live attenuated influenza virus-based flu vaccine licensing business, development of the antimicrobial BDM-I for the treatment of serious infectious diseases, scrambled antigen vaccine and viral vector systems. The company was founded on May 18, 2001 and is headquartered in South Melbourne, Australia. | 2 years |
| Cheryl Hayman | F | - | 1 years | |
| Larisa Rudenko | M | 81 |
BioDiem Ltd.
BioDiem Ltd. Pharmaceuticals: MajorHealth Technology BioDiem Ltd. operates as a biotechnology company. It focuses on development and commercialization of pharmaceutical and biomedical research, vaccines and infectious disease therapies and securing licences of biopharmaceutical products currently under development. The firm's development programs include: expansion of the live attenuated influenza virus-based flu vaccine licensing business, development of the antimicrobial BDM-I for the treatment of serious infectious diseases, scrambled antigen vaccine and viral vector systems. The company was founded on May 18, 2001 and is headquartered in South Melbourne, Australia. | - |
| Josephine Lorenz | F | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Justin Mouchacca | M | - |
Leydin Freyer Corporate Pty Ltd.
 Leydin Freyer Corporate Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Vistra Group Ltd., Leydin Freyer Corporate Pty Ltd. is an Australian company that provides accounting services. The private company is based in South Melbourne, Australia. The company was founded by Melanie Jaye Leydin. Leydin Freyer Corporate was acquired by Vistra Ltd. on November 01, 2021. | 8 years |
| Kevin W. Nichol | M | - |
Victorian Gold Mines NL
 Victorian Gold Mines NL Precious MetalsNon-Energy Minerals Victorian Gold Mines NL explores gold mines. Its projects include Bright, Moliagul, Wedderburn and Great Southern Sheeps Head. The company was founded on September 9, 2009 and is headquartered in Bendigo, Australia. | 5 years |
| Mark Simari | M | 54 | 15 years | |
| Ranko Matic | M | 56 | 7 years | |
| Garrick Ralph Higgins | M | 68 | 10 years | |
| Danie van den Bergh | M | - | 3 years | |
| Peter James Avery | M | 62 |
Victorian Gold Mines NL
Victorian Gold Mines NL Precious MetalsNon-Energy Minerals Victorian Gold Mines NL explores gold mines. Its projects include Bright, Moliagul, Wedderburn and Great Southern Sheeps Head. The company was founded on September 9, 2009 and is headquartered in Bendigo, Australia. | 4 years |
| Philip Thick | M | 64 | 7 years | |
| Ernest Eadie | M | 70 | 15 years | |
| Gregory Toll | M | 71 | 12 years | |
| Guy Ralph Burnett | M | 55 | 4 years | |
| David Leavy | M | - | 4 years | |
| Tolga Kumova | M | 46 | 7 years | |
| Jennifer Currie | F | - | 4 years | |
| Timothy Markwell | M | - | 6 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Australia | 95 | 95.00% |
| United States | 5 | 5.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Melanie Leydin
- Personal Network
